All Type of News
Korean drugmakers urged to strengthen GMP related documentation and design
Domestic pharmaceutical firms will need to fully prepare for the complete documentation, facility and machinery designs when they receive GMP related inspection from the European Medicine Agency (EMEA), according to a...
MSD Korea, CJ to co-market Singulair
CJ Cheil Jedang and MSD Korea announced on September 22 that the two companies have signed an agreement to co-market Singulair (montelukast sodium) in Korea.
Singulair is indicated for the prophylaxis and chronic ...
Korea to cooperate with China over pharmaceutical distribution sector
Chairman Lee Han-woo of the Korea Association of Pharmaceutical Wholesaler agreed with senior officials of the China Association of Pharmaceutical Commerce (CAPC) to make joint efforts to strengthen business cooperati...
LG Life Sciences to conduct Phase 3 clinical trials over new diabetes treatment
LG Life Sciences (LGLS), a Korean pharmaceutical manufacturer, said on September 22 that it will begin Phase III clinical trials for LC15-0444, a new anti-diabetic agent, in Korea and India.
LC15-0444, a dipeptidyl...
Green Cross joins WHO-led flu vaccine bidding
Green Cross Corporation said on September 22 that it has a large bid for a World Health Organization (WHO) program to provide 400 million doses of Influenza A (H1N1) flu vaccine to South America.
The company has su...
Choong-wae shares boosted by new anticancer agent
Shares of Choong-wae Pharm, a leading pharmaceutical firm, were boosted on September 21 by expectations that the company recently won the US patent of new anticancer agent and this may help lift earnings in the years ...
Binex to sign KITEC over commissioned management of KBCC in October
Korea Institute of Industrial Technology (KITEC) will sign an agreement with Binex Co., Ltd. on October to commission the overall management of the Korea Biotechnology Commercialization Center (KBCC) for the next 10 y...
US FDA approves Korean EPO drug
Hanmi Pharm said on September 17 it has received approval from the U.S. Food and Drug Administration to conduct Phase I clinical trial of a new erythropoietin (EPO) for the treatment of anemia.
The company said the...
Wooridul Life Sciences to be split into two in December
Wooridul Life Sciences Ltd. will be split into two – Wooridul Pharm and Wooridul Life Sciences – in December.
Shareholders will get 58 shares of Wooridul Pharm in exchange for 100 Wooridul shares, and 42 shares of ...
KFDA to expand vaccine related manpower
Amid more than 10,000 cases infected with the H1NI flu virus here, the Korea Food and Drug Administration has unveiled its plan to hire 40 regular experts involved in vaccine related sector.
The recruitment plan ca...
